NCT06811441 Third Wave of the EVAL-PLH (POLYhandicap) Cohort: New Eyes
| NCT ID | NCT06811441 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique Hopitaux De Marseille |
| Condition | Polyhandicap |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,102 participants |
| Start Date | 2025-10-13 |
| Primary Completion | 2028-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,102 participants in total. It began in 2025-10-13 with a primary completion date of 2028-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The general objective of the EVAL-PolyNE project is to improve the representativeness of the EVAL-PLH cohort by broadening participation in the John Bost Foundation, due to its geographical particularity and its private valence.
Eligibility Criteria
Inclusion Criteria: * Patient with PIMD/Polyhandicap * Patient for whom the legal representative has received the information note of the EVAL-PLH cohort and has not expressed opposition to the collection of patient data; * Patient aged at least 3 years; * Patient affiliated to a health insurance scheme; * Patient treated within the department of the participating center; * Patient for whom the legal representative understands the French language; * Patient with a PIMD/Polyhandicap Family caregivers of patient * Subject identified by the care structure as the reference family caregiver; * Subject aged at least 18 years; * Subject who understands the French language and is able to complete self-questionnaires; * Subject who has received the information notice and has not expressed opposition to participating in this project Institutinal caregivers of patient * Subject identified by the care structure as the reference institutional caregiver of at least one patient included in this project; * Subject aged at least 18 years; * Subject who understands the French language and is able to complete self-questionnaires; * Subject who has received the information notice and has not expressed opposition to participating in this project. Exclusion Criteria: * Patient with PIMD/Polyhandicap * Patient not meeting all inclusion criteria; * Patient in exclusion period of another research protocol at the time of inclusion. Family and Institutional caregivers of patient • Subject not meeting all inclusion criteria
Contact & Investigator
karine Baumstarck
PRINCIPAL INVESTIGATOR
Assistance Publique des Hôpitaux de Marseille (AP-HM)
Frequently Asked Questions
Who can join the NCT06811441 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, studying Polyhandicap. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06811441 currently recruiting?
Yes, NCT06811441 is actively recruiting participants. Contact the research team at karine.baumstarck@univ-amu.fr for enrollment information.
Where is the NCT06811441 trial being conducted?
This trial is being conducted at Hendaye, France, Hyères, France, La Force, France, Marseille, France and 2 additional locations.
Who is sponsoring the NCT06811441 clinical trial?
NCT06811441 is sponsored by Assistance Publique Hopitaux De Marseille. The principal investigator is karine Baumstarck at Assistance Publique des Hôpitaux de Marseille (AP-HM). The trial plans to enroll 1,102 participants.